Researchers at the University of Pittsburgh have found special high-risk cells in the fallopian tubes that may trigger ...

US-based pharmaceutical company AbbVie has reported the final analysis from the Phase III MIRASOL trial, which assessed its ...

There are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...

According to a new analysis of a population index, the use of oral contraceptives, aka birth control, and a greater number of ...

AbbVie has pointed to a very strong launch trajectory for Elahere, with sales rocketing to $480 million last year, almost ...

Watch the complete video to know the warning signs that the body may send when you are suffering from ovarian cancer. It ...

Researchers have discovered the likely origin of a deadly form of ovarian cancer, offering new hope for early detection and ...

Ovarian cancer may present a threat to the fallopian tubes and peritoneum. Oncologists Dr. Sai Lakshmi Daayana and Dr. Ajay ...

Promising therapies for platinum-resistant ovarian cancer produced mixed results in separate trials. The AKT inhibitor ...

Researchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer: a subset of ...

Elizabeth K. Lee, MD, a medical oncologist in the gynecologic oncology program at Dana-Farber, presented results from a phase ...

AbbVie's Elahere maintains strong efficacy in the Phase 3 MIRASOL trial for ovarian cancer, with durable survival benefits ...